Health Newsfeed – Johns Hopkins Medicine Podcasts

Anchor lead: Can delirium be avoided when someone has an ICU stay? Elizabeth Tracey reports Can a bundle of strategies known as A to F help people in the ICU avoid developing delirium as well as other treatment related problems, as reported recently? Yes, says Dale Needham, an early mobilization pioneer in critical care medicine […]

Anchor lead: Will a new, lower priced hearing aid encourage more people to use them? Elizabeth Tracey reports Have you or someone you love experienced hearing loss? You may know that such loss is usually progressive, leads to social isolation and is associated with an increased risk for dementia. Now a newly FDA-approved hearing aid […]

Anchor lead: Will the new Bose hearing aid open the market and improve access? Elizabeth Tracey reports Hearing loss is common as people age, and is associated with an increased risk of dementia. Research is ongoing on whether hearing aids can slow that trajectory, and now a newly approved device developed by Bose is poised […]

Anchor lead: Will a new hearing aid encourage more people to use the devices? Elizabeth Tracey reports The audio manufacturer Bose has recently received FDA approval to market a hearing aid. Nicolas Reed, an audiologist and researcher at Johns Hopkins, heralds this as good news for consumers and other prospective manufacturers of hearing aids. Reed: […]

Anchor lead: Psilocybin’s list of conditions where is may help is expanding, Elizabeth Tracey reports The FDA is reviewing whether the hallucinogenic drug psilocybin should be reclassified to acknowledge areas where it is clinically useful, at the urging of Matthew Johnson, a psilocybin researcher at Johns Hopkins, and colleagues. Johnson says abundant data from clinical […]

Anchor lead: Should the FDA approve psilocybin as a medicine? Elizabeth Tracey reports Psilocybin is a drug that the FDA currently categorizes as having no clinical value, but an initiative underway at Johns Hopkins and several other research facilities is underway to change that. That’s because when used properly, and under specific conditions, the hallucinogenic […]

Anchor lead: You can have an impact on whether you receive a transfusion, Elizabeth Tracey reports For many people who are having surgery, having fewer transfusions is both practical and results in fewer harms, with a recent study in the New England Journal of Medicine looking at outcomes out to six months postoperatively. Steve Frank, […]

Anchor lead: Why are too many transfusions harmful? Elizabeth Tracey reports More and more evidence is mounting that restricting blood transfusions results in fewer problems for patients and is also less expensive, with the latest study in the New England Journal of Medicine looking at outcomes at six months after cardiac surgery. Steve Frank, a […]

Anchor lead: Limiting transfusions is best for all concerned, Elizabeth Tracey reports People who’ve had cardiac surgery and were given fewer transfusions did just as well six months later as those who got more blood, a recent study in the New England Journal of Medicine found. Steve Frank, a transfusion expert at Johns Hopkins, isn’t […]

Anchor lead: Does it make sense that an EPA product would help in cardiovascular disease? Elizabeth Tracey reports Vascepa is the name of a concentrated omega-3 fatty acid product that the manufacturer has released results about ahead of any scientific meeting or validation, showing about a 25% reduction in cardiovascular events in those at risk […]